惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

L
LangChain Blog
Recent Announcements
Recent Announcements
GbyAI
GbyAI
H
Hackread – Cybersecurity News, Data Breaches, AI and More
Microsoft Azure Blog
Microsoft Azure Blog
N
Netflix TechBlog - Medium
人人都是产品经理
人人都是产品经理
MongoDB | Blog
MongoDB | Blog
D
DataBreaches.Net
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
WordPress大学
WordPress大学
U
Unit 42
腾讯CDC
D
Docker
The GitHub Blog
The GitHub Blog
阮一峰的网络日志
阮一峰的网络日志
Vercel News
Vercel News
I
InfoQ
Jina AI
Jina AI
爱范儿
爱范儿
宝玉的分享
宝玉的分享
博客园 - Franky
G
Google Developers Blog
P
Proofpoint News Feed

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Swedish Orphan Biovitrum AB (publ) (SWOBY) Q1 2026 Earnin...
SA Transcripts · 2026-04-28 · via All Articles on Seeking Alpha

Swedish Orphan Biovitrum AB (publ) (SWOBY) Q1 2026 Earnings Call April 28, 2026 6:30 AM EDT

Company Participants

Guido Oelkers - CEO & President
Lydia Abad-Franch - Senior VP, Head of R&D & Medical Affairs and Chief Medical Officer
Henrik Stenqvist - Chief Financial Officer

Conference Call Participants

Xue Chen - Barclays Bank PLC, Research Division
Christopher Uhde - SEB, Research Division
Kirsty Ross-Stewart - BNP Paribas, Research Division
Mattias Häggblom - Handelsbanken Capital Markets AB, Research Division
Harry Gillis - Joh. Berenberg, Gossler & Co. KG, Research Division
Georg Tigalonov-Bjerke - ABG Sundal Collier Holding ASA, Research Division

Presentation

Operator

Ladies and gentlemen, welcome to the Sobi Q1 2026 Report Conference Call and Live Webcast. I am Valentina, the Chorus Call operator. [Operator Instructions] The conference is being recorded. [Operator Instructions] The conference must not be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to Guido Oelkers, CEO. Please go ahead.

Guido Oelkers
CEO & President

Thank you. Hello, everyone. This is Guido Oelkers, CEO of Sobi. We are delighted to welcome you to the first quarter 2026 conference call for investors and analysts. Our presentation was posted on sobi.com earlier today. Please turn to the next slide. We would like to remind you of the usual provisions on statements about expectations and projections of future events. Unless stated otherwise, we are making comments that mostly relate to the first quarter at constant exchange rates in million Swedish krona.

Please turn to the next slide. Today, we plan to cover the key aspects of our Q1 report. I'm joined by Henrik Stenqvist, our CFO; and Lydia Abad-Franch, Head of R&D and Chief Medical Officer. We plan to review the presentation first and then have a Q&A until around 1:30 p.m. Central Eastern European Time. [Operator Instructions] Please turn to the next slide.